Varisolve polidocanol microfoam: Phase III started

BTG began a 6-month, double-blind, placebo-controlled, U.S. Phase III trial (Study VV017) to evaluate 0.5% or 1.0% Varisolve following endovenous thermal ablation in 105 patients. The company also wit...